Clopidogrel can reduce thrombotic risks in systemic lupus erythematosus by preventing platelet aggregation. It’s generally less potent than anticoagulants like warfarin.

Clopidogrel, an antiplatelet, may lower thrombosis in lupus patients. Its effectiveness varies compared to immunosuppressants or corticosteroids, which target immune dysregulation.